These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11739964)

  • 1. Reporting clinical trials: full access to all the data.
    Rosenberg RN; Aminoff M; Boller F; Soelberg P; Griggs RC; Hachinski V; Hallett M; Johnson RT; Kennard C; Lang AE; Lees AJ; Lisak R; Newsom-Davis J; Pedley TA; Selzer ME; Zochodne D
    Stroke; 2001 Dec; 32(12):2734. PubMed ID: 11739964
    [No Abstract]   [Full Text] [Related]  

  • 2. Guidelines for clinical investigator involvement in industry-sponsored clinical trials. SAEM Research Committee.
    Panacek EA; Lewis RJ
    Acad Emerg Med; 1995 Jan; 2(1):43-5. PubMed ID: 7606612
    [No Abstract]   [Full Text] [Related]  

  • 3. Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials.
    Matcham J; Julious S; Pyke S; O'Kelly M; Todd S; Seldrup J; Day S
    Pharm Stat; 2011; 10(1):70-3. PubMed ID: 20187020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The difficult relationship of industry and science. Money versus research].
    Wessling A
    Pflege Z; 2011 Aug; 64(8):454-5. PubMed ID: 21882617
    [No Abstract]   [Full Text] [Related]  

  • 5. Industry funding and author-industry affiliation in clinical trials in psychiatry.
    Montgomery JH
    Am J Psychiatry; 2006 Jun; 163(6):1110-1; author reply 1111. PubMed ID: 16741218
    [No Abstract]   [Full Text] [Related]  

  • 6. Ethics and industry-sponsored research.
    Kuebler C; Nimmo WS; von R; Gillings D; Morgan AT; Kendle C; Covington PS
    CMAJ; 2002 Mar; 166(5):579-80; author reply 582. PubMed ID: 11898930
    [No Abstract]   [Full Text] [Related]  

  • 7. Design and reporting modifications in industry-sponsored comparative psychopharmacology trials.
    Safer DJ
    J Nerv Ment Dis; 2002 Sep; 190(9):583-92. PubMed ID: 12357091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reporting clinical trials: full access to all the data. Author's right to access to all data obtained in their study.
    Rosenberg RN; Aminoff M; Boller F; Soerensen PS; Griggs RC; Hachinski V; Hallett M; Johnson RT; Kennard C; Lang AE; Lees AJ; Lisak R; Newsom-Davis J; Pedley TA; Selzer ME; Zochodne D
    J Neurol; 2002 May; 249(5):638-9. PubMed ID: 12021961
    [No Abstract]   [Full Text] [Related]  

  • 9. Industry-sponsored pharmaceutical trials and research ethics boards: are they cloaked in too much secrecy?
    Ferris LE
    CMAJ; 2002 May; 166(10):1279-80. PubMed ID: 12041844
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical investigators and the pharmaceutical industry.
    Newman TJ
    N Engl J Med; 2000 Aug; 343(7):510-1. PubMed ID: 10950675
    [No Abstract]   [Full Text] [Related]  

  • 11. How should adverse events be reported in US clinical trials?: ethical considerations.
    Shamoo AE; Katzel LI
    Clin Pharmacol Ther; 2008 Aug; 84(2):275-8. PubMed ID: 18305454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research for profit.
    Spence D
    BMJ; 2006 May; 332(7550):1155-6. PubMed ID: 16690684
    [No Abstract]   [Full Text] [Related]  

  • 13. An analysis of finder's fees in clinical research.
    Maher EA
    CMAJ; 1994 Jan; 150(2):252-6. PubMed ID: 8287347
    [No Abstract]   [Full Text] [Related]  

  • 14. [Expectations of the bearer of the cost of clinical studies and transformation to care by physicians under contract].
    Perleth M
    Dtsch Med Wochenschr; 2005 Jul; 130 Suppl 2():S72-6. PubMed ID: 15988672
    [No Abstract]   [Full Text] [Related]  

  • 15. Industry-sponsored clinical research: a broken system.
    Angell M
    JAMA; 2008 Sep; 300(9):1069-71. PubMed ID: 18768418
    [No Abstract]   [Full Text] [Related]  

  • 16. Legal and ethical issues associated with patient recruitment in clinical trials: the case of competitive enrolment.
    Caulfield T
    Health Law Rev; 2005; 13(2-3):58-61. PubMed ID: 16459415
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dishonesty in clinical trials is expensive for the society 3].
    Waldorff S
    Ugeskr Laeger; 2003 Jun; 165(26):2672-3; author reply 2673-4. PubMed ID: 12886557
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dishonesty in clinical trials is expensive for the society 2].
    Lund BA; Nordby G
    Ugeskr Laeger; 2003 Jun; 165(26):2672. PubMed ID: 12886556
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dishonesty in clinical trials is expensive for the society 1].
    Heslet L; Nielsen JD; Schierbeck J
    Ugeskr Laeger; 2003 Jun; 165(26):2671-2. PubMed ID: 12886555
    [No Abstract]   [Full Text] [Related]  

  • 20. Trust in the medical literature--and Viewpoints in JAMA Internal Medicine.
    Steinbrook R; Redberg RF
    JAMA Intern Med; 2013 Jun; 173(12):1047-8. PubMed ID: 23609117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.